Agenda Chronic Liver Disease 2019

Friday, March 8, 2019

Pre-conference Seminar

12:30 p.m.


1 p.m.

Welcome & Introduction

Paul Pockros, MD

1:10 p.m.

Update on HCV and “Non-Invasive” Diagnostics

Paul Pockros, MD

1:40 p.m.

HCV Guidelines on DAAs

Paul Pockros, MD

2:40 p.m.

Break & View Exhibits

3 p.m.

Decompensated Cirrhosis and Transplant

Catherine Frenette, MD

4:20 p.m.

Case Presentation, Discussion and Q&A

Yuki Rosenkoetter, PA-C, MPAS

5 p.m.


Saturday, March 9, 2019

7:30 a.m.            

Registration, Breakfast & View Exhibits

8 p.m.                  

Welcome & Introduction

Paul J. Pockros, MD


Moderator: Paul J. Pockros, MD

8:15 a.m.            

What Has Changed in Systemic Treatment for Hepatocellular Carcinoma

Catherine T. Frenette, MD

8:45 a.m.   

William S. Haubrich Memorial Lecture

Primary Biliary Cirrhosis/Primary Sclerosing Cholangitis

Cynthia Levy, MD

9:15 a.m.            

Alcoholic Liver Disease

Michael R. Lucey, MD

9:45 a.m.            

Break & View Exhibits

10:15 a.m.          

Diet and NAFLD

Terry D. Box, MD

10:45 a.m.          

Debate: Surgical vs. Medical Therapy for NASH

Surgical: Michael R. Lucey, MD

Medical: Catherine T. Frenette, MD


11:45 a.m.          

Lunch & View Exhibits

Chronic Viral Hepatitis

Moderator: Paul J. Pockros, MD

12:45 p.m.          

Update on HCV Guidelines

Paul Kwo, MD

1:15 p.m.          

The New Epidemic on HCV

Christian B. Ramers, MD

1:45 p.m.            

HCV: Benefits of Cure & Post-SVR Management

Paul J. Pockros, MD

2:15 p.m.           

Break & View Exhibits

2:30 p.m.            

Update of HBV Guidelines

Robert G. Gish, MD

3 p.m.                  

Debate: Third Trimester Prophylaxis for Hepatitis B-Is It Really Necessary for High Risk Mothers?

Yes: Robert G. Gish, MD

No: Paul Kwo, MD

3:30 p.m.           

Panel Discussion

4:30 p.m.           


Sunday, March 10, 2019

7:30 a.m.

Breakfast & View Exhibits


8 a.m.

Both Sides of the Coin

Terry D. Box, MD

8:30 a.m.     

Tips on Managing the Hospitalized Cirrhotic: Acute on Chronic Liver Failure in the Liver Transplant Candidate           

I. Raymond Thomason, MD

9 a.m.                  

Debate: Thrombopoietin Receptor Agonists vs. Platelet Infusions

We Should Use Thrombopoietin Agonists for Our Cirrhotic Patients with Thrombocytopenia: I. Raymond Thomason, MD

We Should Use Platelet Infusions for Our Cirrhotic Patients with Thrombocytopenia: Norman L. Sussman, MD

9:30 a.m.            

Break & View Exhibits

10 a.m.               

The Changing Face of Organ Allocation in Liver Transplant

Norman L. Sussman, MD

10:30 a.m.          


Zobair M. Younossi, MD, MPH

11 a.m.               

Panel Discussion

11:30 a.m.         

Final Adjournment

Topics, times and speakers are subject to change